Clovis Oncology
CLVS
#10297
Rank
NZ$20.37 M
Marketcap
NZ$0.14
Share price
0.00%
Change (1 day)
-94.99%
Change (1 year)

Earnings for Clovis Oncology (CLVS)

Earnings in 2022 (TTM): -NZ$0.35 Billion

According to Clovis Oncology's latest financial reports the company's current earnings are NZ$0.13 Billion. In 2021 the company made an earning of -NZ$0.41 Billion, an increase over its 2020 earnings that were of -NZ$0.6 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Clovis Oncology from 2010 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -NZ$0.35 Billion-15.73%
2021 -NZ$0.41 Billion-32.64%
2020 -NZ$0.6 Billion-9.06%
2019 -NZ$0.66 Billion7.49%
2018 -NZ$0.62 Billion4.42%
2017 -NZ$0.59 Billion-8.83%
2016 -NZ$0.65 Billion-0.4%
2015 -NZ$0.65 Billion140.82%
2014 -NZ$0.27 Billion86.64%
2013 -NZ$0.15 Billion19.53%
2012 -NZ$0.13 Billion
2010 -NZ$46.09 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
BioMarin Pharmaceutical
BMRN
NZ$1.17 B-412.45%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$22.65 B-6,121.05%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
NZ$20.51 B-5,551.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$56.07 B-15,001.29%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$2.87 B-863.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$38.95 B-10,451.05%๐Ÿ‡บ๐Ÿ‡ธ USA